Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts

Genital human papillomavirus infection is one of the most common sexually transmitted diseases. Imiquimod is a new agent, an immune-response modifier, that has been demonstrated to have potent in vivo antiviral and antitumor effects in animal models. The present prospective, multicenter, double-blin...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Beutner, Karl R., Tyring, Stephen K., Trofatter, Kenneth F., Douglas, John M., Spruance, Spotswood, Owens, Mary L., Fox, Terry L., Hougham, Andrina J., Schmitt, Kathy A.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105543/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.789
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!